latest news releases from the newsroom
Continental Energy Corp.
Continental Energy Reports Annual Results
DALLAS, Jan. 6, 2005 (PRIMEZONE) -- Continental Energy Corporation (OTCBB:CPPXF) announced today that it has released its Annual Report and audited financial statements for its year ended July 31, 2004, and filed the report with securities regulators on SEDAR.
Brower Piven, A Professional Corporation
Law Offices Of Charles J. Piven, P.A. Announces Class Action Lawsuit Against Atherogenics, Inc. -- AGIX
BALTIMORE, Jan. 6, 2005 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. today announced that a securities class action was commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of Atherogenics, Inc. (Nasdaq:AGIX) between September 28, 2004 and December 31, 2004, inclusive (the "Class Period").
A Strange Young Hero, Evil Men, and Magical Creatures -- New Fantasy Novel Takes Readers to the Secret Land of Boovarians
TRENTON, N.J., Jan. 6, 2005 (PRIMEZONE) -- Wally Wizzlatch was the object of ridicule in school. Even as a child, he was stocky with incongruous physical appearance that it was no exaggeration to liken him to the Neanderthal man. Mentally gifted, Wally learned to deal with the derision and focus on pursuing knowledge. In one of his scientific experiments, Wally is unexpectedly transported to a strange foreign land unknown to the rest of the world, the Dome of Entropy. There he meets an erudite old man who reveals Wally's destiny and tremendous responsibility. When evil forces threaten to wreak havoc on the Dome and the rest of our world, Wally and his newfound friends must find a way to save both worlds. D.R. Caesarson's new science fiction and fantasy novel Scion of the Stone takes readers to a hidden realm wherein lies a mysterious land inhabited by fascinating magical creatures.
The Jordan Company L.P.
The Jordan Company Completes Sale of Permatex Inc.
NEW YORK, Jan. 6, 2005 (PRIMEZONE) -- Principals of The Jordan Company and its affiliates ("Jordan") today announced that Permatex Inc. ("Permatex"), a company formed by Jordan, has completed its merger with a subsidiary of Illinois Tool Works Inc. ("ITW") (NYSE:ITW). As a result of the merger, Jordan has sold its entire interest in Permatex. Terms of the transaction were not disclosed.
Brodsky & Smith, LLC
Law Offices of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Atherogenics, Inc. -- AGIX
BALA CYNWYD, Penn., Jan. 6, 2005 (PRIMEZONE) -- Law offices of Brodsky & Smith, LLC today announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the common stock and other securities of Atherogenics, Inc. ("Atherogenics" or the "Company") (Nasdaq:AGIX), between September 28, 2004 and December 31, 2004 inclusive (the "Class Period"). The class action lawsuit was filed in the United States District Court for the Southern District of New York.
ViroPharma Announces Submission of Investigational New Drug Application for HCV-796
EXTON, Pa., Jan. 6, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that its partner in the development of antiviral compounds targeting hepatitis C (HCV), Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE) has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration to evaluate ViroPharma's compound HCV-796, a novel polymerase inhibitor, as a potential new product to treat hepatitis C. Under this IND, a protocol has been prepared to assess the safety and tolerability of HCV-796 in healthy adult volunteers, as well as to gather pharmacokinetic data. Preclinical studies have shown HCV-796 may be more potent than other anti-HCV compounds developed to date between the two companies.